June
AI with Purpose:
Strategy-First Innovation Across Drug Discovery
STK Steakhouse, San Francisco, CaliforniaOur Agenda
Solving AI-Driven Discovery at Scale – From Concept to Clinical Candidate
1Designing FAIR-Centric Data Platforms for the Future of Multimodal R&D
2
Why you should attend
TOPICS INCLUDE:
• AI & ML implementation in drug discovery workflows
• Data interoperability across therapeutic areas and modalities
• FAIR data practices to enable reusability and collaboration
• Platform strategies that bridge chemistry and biology
Meet Our Facilitators
Dr. David Gosalvez
Chief Strategy Officer Revvity Signals Software
Dr. Anastasia Christianson
Managing Principal EPAM Life Science Consulting & Executive in Residence, Columbia Ventures
More about Revvity
Revvity Signals Software provides an extensive range of scientific solutions, empowering researchers and pharmaceutical pioneers worldwide. Our cutting-edge technology simplifies processes, speeds up experiments, and prioritizes promising compounds, redefining drug discovery. The Signals Research Suite, our flagship solution, streamlines R&D workflows with data capture, collaboration, data processing, and data-driven analytics. It includes i Signals Notebook, the only cloud-native electronic lab notebook with ChemDraw®, Spotfire® powered advanced analytics, as well as next-gen data management. In addition, we have recently introduced Signals Synergy which is designed to substantially enhance collaboration, project management, and data exchange between sponsors and CROs.
Further Information
Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch
Here To Help
Need help registering your team? Just get in touch and a member of the team will be happy to help.
Payment Securely powered by stripe
